Last week I heard that Novartis is going to exercises its right to purchase Additional Shares of Alnylam Common Stock after the both parties investor right agreement in year 2005. This week again Novartis was there in news stand for it purchase of generic injectable business of EBEWE pharma which is based in Austria, the deal is worth $1.2 Billion..........
Thursday, May 21, 2009
Novartis in news this May
Last week I heard that Novartis is going to exercises its right to purchase Additional Shares of Alnylam Common Stock after the both parties investor right agreement in year 2005. This week again Novartis was there in news stand for it purchase of generic injectable business of EBEWE pharma which is based in Austria, the deal is worth $1.2 Billion..........
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment